中山醫學大學機構典藏 CSMUIR:作者相关文件
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 17918/22933 (78%)
造访人次 : 7437626      在线人数 : 62
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻

    类别浏览

    正在载入社群分类, 请稍候....

    年代浏览

    正在载入年代分类, 请稍候....

    "van den Bosch, F"的相关文件  

    回到依作者浏览

    显示 6 项.

    类别 日期 题名 作者 档案
    [中山醫學大學研究成果] 其他文獻 2021 EFFECT OF TOFACITINIB ON PATIENT-REPORTED OUTCOMES IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS FROM A PHASE 3 TRIAL Navarro-Compan, V; Wei, JCC; Van den Bosch, F; Magrey, M; Wang, L; Fleishaker, D; Cappelleri, JC; Wang, C; Wu, J; Dina, O; Fallon, L; Strand, V
    [中山醫學大學研究成果] 其他文獻 2020 ETANERCEPT WITHDRAWAL AND RE-TREATMENT IN PATIENTS WITH INACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS AT 24 WEEKS: RESULTS OF RE-EMBARK, AN OPEN-LABEL, PHASE IV TRIAL Van den Bosch, F; Wei, JCC; Nash, P; Blanco, FJ; Graham, D; Zang, C; Arthur, E; Borlenghi, C; Vlahos, B; Deodhar, A
    [中山醫學大學研究成果] 其他文獻 2020 Predictors of Maintaining Inactive Disease After Etanercept Withdrawal, and Regaining Inactive Disease Status After Flare and Retreatment, in Adults with Non-radiographic Axial Spondyloarthritis: Results from RE-EMBARK Van den Bosch, F; Wei, JCC; Blanco, F; Selema, P; Graham, D; Arthur, E; Tsekouras, V; Vlahos, B; Zang, CB; Deodhar, A; Nash, P
    [中山醫學大學研究成果] 其他文獻 2020 Efficacy Outcomes Following Etanercept Withdrawal by Sustained Remission Status in Patients with Nr-axSpA: Results from RE-EMBARK van den Bosch, F; Nash, P; Wei, JCC; Blanco, F; Tsekouras, V; Zang, CB; Graham, D; Arthur, E; Selema, P; Vlahos, B; Deodhar, A
    [中山醫學大學研究成果] 期刊論文 2021 Ixekizumab Improves Functioning and Health in the Treatment of Radiographic Axial Spondyloarthritis: Week 52 Results from 2 Pivotal Studies Kiltz, U; Wei, JCC; van der Heijde, D; van den Bosch, F; Walsh, JA; Boonen, A; Gensler, LS; Hunter, T; Carlier, H; Dong, Y; Li, XQ; Bolce, R; Strand, V; Braun, J
    [中山醫學大學研究成果] 期刊論文 2020 Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W) Dougados, M; Wei, JCC; Landewe, R; Sieper, J; Baraliakos, X; Van den Bosch, F; Maksymowych, WP; Ermann, J; Walsh, JA; Tomita, T; Deodhar, A; van der Heijde, D; Li, XQ; Zhao, FY; Bertram, CC; Gallo, G; Carlier, H; Gensler, LS

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈